Michael Heartlein
Nessuna posizione attualmente
Profilo
Michael Heartlein is the founder of Translate Bio, Inc., which was founded in 2011.
He held the title of Executive Vice President from 2019 to 2020.
Dr. Heartlein also worked at Shire Human Genetic Therapies, Inc. from 2003 to 2016 as the Head-Messenger RNA Therapeutic.
Dr. Heartlein received his undergraduate degree from Illinois State University in 1980 and his doctorate degree from Oak Ridge Graduate School of Biomedical Sciences in 1984.
Precedenti posizioni note di Michael Heartlein
| Società | Posizione | Fine |
|---|---|---|
| TRANSLATE BIO, INC. | Fondatore | 01/06/2020 |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Corporate Officer/Principal | 01/12/2016 |
Formazione di Michael Heartlein
| Illinois State University | Undergraduate Degree |
| Oak Ridge Graduate School of Biomedical Sciences | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Health Technology |
- Borsa valori
- Insiders
- Michael Heartlein
